US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Virtus LifeSci Biotech Clinical Trials ETF

44.56

-0.4392-0.98%

Post-market: 44.56-0.0038-0.01%19:30 EDT

Volume:9K

Turnover:402.62K

Market Cap:42.34M

PE:- -

High:45.50

Open:45.50

Low:44.26

Close:45.00

52wk High:56.18

52wk Low:27.62

Shares:950.00K

Float Shares:950.00K

Volume Ratio:0.40

T/O Rate:0.95%

Dividend:0.66

Dividend Rate:1.47%

ROE:--

ROA:--

PB:0.96

PE(LYR):- -

Loading ...

Overview Company News Filings

UNITED LAB Receives FDA Clearance for Clinical Trial of Drug Candidate UBT48128

MoonLake shares drop 11% pre-market after Q2 earnings, Phase 3 trial results

From Subsidized Weapons to Deep Gun Culture Love: Why Does Thailand Keep Experiencing Tragic School Shootings?

AbCellera to Report Phase 2 Menopause Therapy Data

The BBC shouldn’t push Londoners to accept antisocial phone behaviour

BBC to broadcast Alexis Ohanian co-founded all-female athletics series Athlos

These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks

Black Diamond Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Moderna announces initiation of Phase 1 trial of mRNA-1469

US President Remarks on Air Force One, Says ABC is Worse Than BBC After Learning Reporter's Affiliation

Essential Morning Digest: Key Stories You Shouldn't Miss

Hugging Face CEO Says AI Firms Must Be Held Accountable for Rogue Bot Attacks

MT Newswires Live

Thalia Therapeutics Updates Voting Rights as RNA Therapy Pipeline Advances

GSK Advances New Toddler Pneumococcal Booster, Signaling Ongoing Vaccine Pipeline Momentum

Moderna Targets Ebola With New mRNA Vaccine Trial: What Investors Should Watch

Biophytis Publishes 2025 Accounts as Trading Resumes Amid Going-Concern Doubts

Grifols says EXCELL Phase 3 trial timeline not ‘new development or a delay’

Zealand Pharma’s New Psoriasis Trial Sets Early Stage for ZP9830

Racura Advances HARNESS-1 Trial After Safe First-Patient Treatment With RC220 Combo

Atea Pharmaceuticals reports C-BEYOND trial meets primary, secondary endpoints

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/BBC/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BBC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBC\",,,,,undefined,":{"symbol":"BBC","market":"US","secType":"STK","nameCN":"Virtus LifeSci Biotech Clinical Trials ETF","latestPrice":44.5638,"timestamp":1790971200000,"preClose":45.003,"halted":0,"volume":9007,"hourTrading":{"tag":"盘后","latestPrice":44.56,"preClose":44.5638,"latestTime":"19:30 EDT","volume":13,"amount":579.258,"timestamp":1790983804096,"change":-0.0038,"changeRate":-0.000085,"amplitude":0},"delay":0,"changeRate":-0.00975934937670821,"floatShares":950000,"shares":950000,"eps":0,"marketStatus":"Market Closed","change":-0.4392,"latestTime":"10-02 16:00:00 EDT","open":45.5,"high":45.5,"low":44.26,"amount":402619.38503999996,"amplitude":0.027554,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":45.003,"sharesOutstanding":900004,"nav":44.548,"aum":42321005.38,"dividendRate":0.014714,"bidAskSpread":0.002193,"postHourTrading":{"tag":"盘后","latestPrice":44.56,"preClose":44.5638,"latestTime":"19:30 EDT","volume":13,"amount":579.258,"timestamp":1790983804096,"change":-0.0038,"changeRate":-0.000085,"amplitude":0},"volumeRatio":0.40334787043929554,"impliedVol":0.3288,"impliedVolPercentile":0.498},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BBC\",,,,,undefined,":{"symbol":"BBC","floatShares":950000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.40334787043929554,"shares":950000,"dividePrice":0.6557,"high":45.5,"amplitude":0.027554,"preClose":45.003,"low":44.26,"week52Low":27.62,"pbRate":"0.96","week52High":56.18,"institutionHeld":0,"latestPrice":44.5638,"eps":0,"divideRate":0.014714,"volume":9007,"delay":0,"ttmEps":0,"open":45.5,"prevYearClose":38.56,"prevWeekClose":45.1452,"prevMonthClose":46.2948,"prevQuarterClose":46.2948,"fiveDayClose":45.1452,"twentyDayClose":53.39,"sixtyDayClose":54.87},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BBC\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"BBC","amount":0.65544,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-29","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-29"},{"date":"2024-12-20","symbol":"BBC","amount":0.23947,"announcedDate":"2024-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-20","defaultRemindTime":1734705000000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-27","payableDate":"2024-12-20","currency":"USD","dateTimestamp":1734670800000,"payDate":"2024-12-27"},{"date":"2023-12-20","symbol":"BBC","amount":0.0823,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"Virtus LifeSci Biotech Clinical Trials ETF","recordDate":"2023-12-29","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-29"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BBC\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-29","value":0.0823,"currency":"USD"},{"executeDate":"2024-12-20","recordDate":"2024-12-20","paymentDate":"2024-12-27","value":0.23947,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-29","value":0.65544,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BBC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BBC\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1172660963","title":"UNITED LAB Receives FDA Clearance for Clinical Trial of Drug Candidate UBT48128","url":"https://stock-news.laohu8.com/highlight/detail?id=1172660963","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172660963?lang=en_us&edition=fundamental","pubTime":"2026-08-11 18:12","pubTimestamp":1786443159,"startTime":"0","endTime":"0","summary":"UNITED LAB (03933) announced that its wholly-owned subsidiary, United Biotechnology (Zhuhai Hengqin) Co., Ltd., has received approval from the U.S. Food and Drug Administration (FDA) for its...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3M56506.USD","03933","BBC","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658935473","title":"MoonLake shares drop 11% pre-market after Q2 earnings, Phase 3 trial results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658935473","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658935473?lang=en_us&edition=fundamental","pubTime":"2026-08-10 19:50","pubTimestamp":1786362626,"startTime":"0","endTime":"0","summary":"07:45 EDT MoonLake shares drop 11% pre-market after Q2 earnings, Phase 3 trial results Published first on TheFly – the ultimate source for real-tim...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moonlake-shares-drop-11-pre-market-after-q2-earnings-phase-3-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moonlake-shares-drop-11-pre-market-after-q2-earnings-phase-3-trial-results-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","GXDW","PMDE","JOYT","VGFPF","RGLO","FEBU","DECU","PSIL","VOTE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102350882","title":"From Subsidized Weapons to Deep Gun Culture Love: Why Does Thailand Keep Experiencing Tragic School Shootings?","url":"https://stock-news.laohu8.com/highlight/detail?id=1102350882","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102350882?lang=en_us&edition=fundamental","pubTime":"2026-08-08 08:40","pubTimestamp":1786149648,"startTime":"0","endTime":"0","summary":"A school shooting in Nonthaburi province, Thailand, on the morning of August 7, local time, marks the second such incident on a school campus in the country this year. This event highlights ongoing...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657292236","title":"AbCellera to Report Phase 2 Menopause Therapy Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2657292236","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657292236?lang=en_us&edition=fundamental","pubTime":"2026-08-08 05:19","pubTimestamp":1786137583,"startTime":"0","endTime":"0","summary":"AbCellera Biologics ( ($ABCL) ) has provided an update. On August 7, 2026, AbCellera announced it will release top-line data from its Phase 2 trial...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/abcellera-to-report-phase-2-menopause-therapy-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/abcellera-to-report-phase-2-menopause-therapy-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSIL","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657642903","title":"The BBC shouldn’t push Londoners to accept antisocial phone behaviour","url":"https://stock-news.laohu8.com/highlight/detail?id=2657642903","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657642903?lang=en_us&edition=fundamental","pubTime":"2026-08-07 22:46","pubTimestamp":1786113999,"startTime":"0","endTime":"0","summary":"The author notes that boomboxes back in the day also “caused a stir”, in a clumsy effort to suggest that antisocial blaring on the bus somehow amounts to a digital sub-culture. Laced throughout is the argument that inflicting tinny device speakers on carriage-fulls of commuters represents a contemporary form of youth protest movement. But the effect is less Arab Spring and more Ali G.Thin comparisons are made to early objections to phone calls made on 1990s mobiles, though this serves mainly to highlight how far we have slid since then – the slow descent from public calls, then loud speaker conversations down to playing music out-loud.Social soundscapes or antisocial behaviour?","market":"nz","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/08/GettyImages-2219717302.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/08/GettyImages-2219717302.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/bbc-push-londoners-antisocial-phone-behaviour/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/bbc-push-londoners-antisocial-phone-behaviour/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657114636","title":"BBC to broadcast Alexis Ohanian co-founded all-female athletics series Athlos","url":"https://stock-news.laohu8.com/highlight/detail?id=2657114636","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657114636?lang=en_us&edition=fundamental","pubTime":"2026-08-07 16:45","pubTimestamp":1786092349,"startTime":"0","endTime":"0","summary":"The BBC will broadcast the Alexis Ohanian co-founded Athlos The BBC will broadcast the Alexis Ohanian co-founded all-female athletics meet Athlos when it heads to London next month.The event, one of a number on a series funded by the Reddit co-founder, will land at Prem Rugby team Saracens’ Stone X Stadium in September with the likes of Keely Hodgkinson, Sha’Carri Richardson, Gabby Thomas and Georgia Hunter Bell set to feature.Athlos is funded by Serena Williams’ husband Ohanian’s Seven Seven Six early-stage venture capital firm, which has nearly $1b in assets under management. It holds additional from both Richardson and Thomas, as well as Tara Davis-Woodhall.The organisation’s acting president Kayla Green said: “The BBC is where the UK falls in love with athletics, and there’s no better partner to introduce Athlos to British fans.”","market":"us","thumbnail":"https://www.cityam.com/wp-content/uploads/2026/08/GettyImages-2286638568-e1786092089505.jpg?w=400&h=225&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2026/08/GettyImages-2286638568-e1786092089505.jpg?w=400&h=225&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/bbc-to-broadcast-alexis-ohanian-co-founded-all-female-athletics-series-athlos/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/bbc-to-broadcast-alexis-ohanian-co-founded-all-female-athletics-series-athlos/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657699541","title":"These New Drugs Could Fuel Fresh Highs for Biotech and Pharma Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2657699541","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657699541?lang=en_us&edition=fundamental","pubTime":"2026-08-07 13:15","pubTimestamp":1786079700,"startTime":"0","endTime":"0","summary":"Biotech stocks have recaptured investors' attention this year amid a wave of drug innovation, which is spurring merger-and-acquisition activity in the biopharma industry and a fresh round of initial p","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VHT","LU1934455194.USD","IE000M9KFDE8.USD","SG9999001440.SGD","LU0306807586.USD","BK4578","GDOC","FHLC","MRK","LU2596442595.SGD","PSIL","XLV","IHE","LU1941712348.USD","NVS","LU0965508806.USD","RXL","LU1061106388.HKD","HRTS","IE00BJJMRZ35.SGD","XBI","LU1261432733.SGD","LU1037948541.HKD","LU1974910355.USD","IE00B1BXHZ80.USD","LU0456855351.SGD","LU2491050154.USD","NVIB","LU0061475181.USD","BMED","MEDX","LU0122379950.USD","BBC","TRUH","IYH","LU2461242641.AUD","LU1929549753.HKD","PBLS","LU1430594728.SGD","BMY","JDOC","SG9999014575.USD","PPH","FTXH","LU0320765489.SGD","PAWZ","LU2125154778.USD","IXJ","LU1023059063.AUD","LU0980610538.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657152527","title":"Black Diamond Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2657152527","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657152527?lang=en_us&edition=fundamental","pubTime":"2026-08-06 04:01","pubTimestamp":1785960060,"startTime":"0","endTime":"0","summary":"Presented positive Phase 2 results for silevertinib in frontline patients with non-classical EGFRm NSCLC at the 2026 ASCO Annual Meeting, including that no patients developed de novo brain metastases ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/05/3339642/0/en/Black-Diamond-Therapeutics-Reports-Second-Quarter-2026-Financial-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSIL","BK4139","BDTX","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656557491","title":"Moderna announces initiation of Phase 1 trial of mRNA-1469","url":"https://stock-news.laohu8.com/highlight/detail?id=2656557491","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656557491?lang=en_us&edition=fundamental","pubTime":"2026-08-04 23:05","pubTimestamp":1785855923,"startTime":"0","endTime":"0","summary":"Moderna (MRNA) announced that following Health Canada’s authorization of the study, the first participants have been vaccinated in a Phase 1 clinic...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/moderna-announces-initiation-of-phase-1-trial-of-mrna-1469-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/moderna-announces-initiation-of-phase-1-trial-of-mrna-1469-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4568","MRNA","BBC","BK4533","MRNX","BK4501","MRNY","BK4585","BK4534","BK4548","BK4551","WDNA","BK4139","BK4532","BK4588","IDNA","LGHT","GNOM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113293278","title":"US President Remarks on Air Force One, Says ABC is Worse Than BBC After Learning Reporter's Affiliation","url":"https://stock-news.laohu8.com/highlight/detail?id=1113293278","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113293278?lang=en_us&edition=fundamental","pubTime":"2026-08-03 13:00","pubTimestamp":1785733218,"startTime":"0","endTime":"0","summary":"On August 2 local time, while responding to a question from a reporter aboard Air Force One, US President Donald Trump repeatedly asked which media outlet the reporter represented. Upon learning the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1163548756","title":"Essential Morning Digest: Key Stories You Shouldn't Miss","url":"https://stock-news.laohu8.com/highlight/detail?id=1163548756","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163548756?lang=en_us&edition=fundamental","pubTime":"2026-08-03 07:11","pubTimestamp":1785712273,"startTime":"0","endTime":"0","summary":"Provincial residents looking to start a bed and breakfast or a coffee shop in Guiyang can now benefit from significantly faster approval processes. This summer, the city of \"Cool Guiyang\" is...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656018394","title":"Hugging Face CEO Says AI Firms Must Be Held Accountable for Rogue Bot Attacks","url":"https://stock-news.laohu8.com/highlight/detail?id=2656018394","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656018394?lang=en_us&edition=fundamental","pubTime":"2026-08-01 06:36","pubTimestamp":1785537366,"startTime":"0","endTime":"0","summary":"Hugging Face Chief Executive Clement Delangue said AI developers should be held accountable when their models carry out cyber attacks, BBC reported Friday, after a rogue OpenAI bot breached the company's systems earlier this month.Delangue said Hugging Face rebuilt about a third of its IT network following the incident and would not sue OpenAI, but stressed cyber attacks remain illegal and should not become normalized, BBC reported.Anthropic also disclosed Friday that its Claude chatbot attacked three companies after escaping a testing environment, with the company only discovering the incidents during a review prompted by the OpenAI case, BBC reported.The incidents have sparked debate over who should be held liable when AI agents autonomously carry out cyber attacks after escaping testing sandboxes, BBC reported.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["VTHR","CHAT","AIPO","QTOC","ARTY","AGIX","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655035713","title":"Thalia Therapeutics Updates Voting Rights as RNA Therapy Pipeline Advances","url":"https://stock-news.laohu8.com/highlight/detail?id=2655035713","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655035713?lang=en_us&edition=fundamental","pubTime":"2026-07-31 18:12","pubTimestamp":1785492749,"startTime":"0","endTime":"0","summary":"An update from N4 Pharma ( ($GB:THAT) ) is now available. Thalia Therapeutics plc, an AIM-listed clinical-stage biotech specialising in RNA-based t...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/thalia-therapeutics-updates-voting-rights-as-rna-therapy-pipeline-advances?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/thalia-therapeutics-updates-voting-rights-as-rna-therapy-pipeline-advances?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","BK4139","RNA","BK4588","BK4505","BK4585","IE0009354923.USD","XBIX","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655804705","title":"GSK Advances New Toddler Pneumococcal Booster, Signaling Ongoing Vaccine Pipeline Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2655804705","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655804705?lang=en_us&edition=fundamental","pubTime":"2026-07-31 00:32","pubTimestamp":1785429167,"startTime":"0","endTime":"0","summary":"GlaxoSmithKline ($GSK) announced an update on their ongoing clinical study. GlaxoSmithKline is running a Phase 1 trial called “A Phase 1, Observer-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/gsk-advances-new-toddler-pneumococcal-booster-signaling-ongoing-vaccine-pipeline-momentum?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/gsk-advances-new-toddler-pneumococcal-booster-signaling-ongoing-vaccine-pipeline-momentum?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","GSKH","LU1829250122.USD","BK4588","GSK","BK4007","GSK.UK","BK4532","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655804084","title":"Moderna Targets Ebola With New mRNA Vaccine Trial: What Investors Should Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2655804084","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655804084?lang=en_us&edition=fundamental","pubTime":"2026-07-31 00:31","pubTimestamp":1785429105,"startTime":"0","endTime":"0","summary":"Moderna ($MRNA) announced an update on their ongoing clinical study. Moderna (MRNA) is launching a Phase 1 trial of its mRNA-1469 vaccine to preven...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/moderna-targets-ebola-with-new-mrna-vaccine-trial-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/moderna-targets-ebola-with-new-mrna-vaccine-trial-what-investors-should-watch?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4534","IDNA","ISBC","BK4551","BK4139","LGHT","BK4585","BK4568","MRNX","MRNY","BBC","BK4501","BK4211","WDNA","BK4588","GNOM","BK4533","BK4532","BK4548","MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655801296","title":"Biophytis Publishes 2025 Accounts as Trading Resumes Amid Going-Concern Doubts","url":"https://stock-news.laohu8.com/highlight/detail?id=2655801296","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655801296?lang=en_us&edition=fundamental","pubTime":"2026-07-30 23:59","pubTimestamp":1785427179,"startTime":"0","endTime":"0","summary":"Biophytis ( ($BPTSY) ) has provided an announcement. Biophytis SA, a Paris-based clinical-stage biotechnology group focused on age-related diseases...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biophytis-publishes-2025-accounts-as-trading-resumes-amid-going-concern-doubts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biophytis-publishes-2025-accounts-as-trading-resumes-amid-going-concern-doubts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBP","FHLC","BK4588","JDOC","AGNG","SYNB","LNGR","IBB","BBC","FWD","RSPH","BK4585","IEIH","XT","DARP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655890242","title":"Grifols says EXCELL Phase 3 trial timeline not ‘new development or a delay’","url":"https://stock-news.laohu8.com/highlight/detail?id=2655890242","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655890242?lang=en_us&edition=fundamental","pubTime":"2026-07-30 01:55","pubTimestamp":1785347731,"startTime":"0","endTime":"0","summary":"Grifols (GRFS) issued the following statement on the EXCELL Phase 3 trial timeline: “We have noted the recent Bloomberg article referring to the EX...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/grifols-says-excell-phase-3-trial-timeline-not-new-development-or-a-delay-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/grifols-says-excell-phase-3-trial-timeline-not-new-development-or-a-delay-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GRFS","BK4139","PSIL","BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655897831","title":"Zealand Pharma’s New Psoriasis Trial Sets Early Stage for ZP9830","url":"https://stock-news.laohu8.com/highlight/detail?id=2655897831","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655897831?lang=en_us&edition=fundamental","pubTime":"2026-07-30 00:32","pubTimestamp":1785342730,"startTime":"0","endTime":"0","summary":"Zealand Pharma A/S ($ZLDPF) announced an update on their ongoing clinical study. Zealand Pharma A/S (ZLDPF) has opened a new Phase 1 trial in plaqu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/zealand-pharmas-new-psoriasis-trial-sets-early-stage-for-zp9830?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/zealand-pharmas-new-psoriasis-trial-sets-early-stage-for-zp9830?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC","BK4139","ZLDPF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655839781","title":"Racura Advances HARNESS-1 Trial After Safe First-Patient Treatment With RC220 Combo","url":"https://stock-news.laohu8.com/highlight/detail?id=2655839781","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655839781?lang=en_us&edition=fundamental","pubTime":"2026-07-29 07:59","pubTimestamp":1785283143,"startTime":"0","endTime":"0","summary":"Race Oncology Ltd. ( ($AU:RAC) ) has shared an announcement. Racura Oncology reported that the first patient in its HARNESS-1 Phase 1 trial has bee...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/racura-advances-harness-1-trial-after-safe-first-patient-treatment-with-rc220-combo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/racura-advances-harness-1-trial-after-safe-first-patient-treatment-with-rc220-combo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654009645","title":"Atea Pharmaceuticals reports C-BEYOND trial meets primary, secondary endpoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2654009645","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654009645?lang=en_us&edition=fundamental","pubTime":"2026-07-28 19:21","pubTimestamp":1785237677,"startTime":"0","endTime":"0","summary":"Atea Pharmaceuticals (AVIR) announced topline results from C-BEYOND, its Phase 3 trial conducted in North America evaluating the once-daily fixed-d...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/atea-pharmaceuticals-reports-c-beyond-trial-meets-primary-secondary-endpoints-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/atea-pharmaceuticals-reports-c-beyond-trial-meets-primary-secondary-endpoints-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AVIR","BBC","BK4007","PSIL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":5,"totalSize":161,"code":"91000000","status":"200"}]}}